Read articles from Global

June 02, 2026 by drinkanddrugsnews.com

Drug and alcohol services are encouraged to make smoking reduction a routine part of harm reduction support. Smoking rates among people in treatment remain far higher than in the general population, creating a major but often overlooked health inequality. Safer nicotine products are presented as practical tools that can help people reduce or stop smoking without requiring immediate nicotine abstinence. Integrating tobacco harm reduction into drug services could offer a low-cost, high-impact way to improve health outcomes for people facing multiple disadvantages. The guide calls for more realistic, compassionate support that meets people where they are and gives them better options than continued smoking.

June 02, 2026 by filtermag.org

The World Health Organization’s approach to nicotine pouches is criticised for focusing on nicotine use rather than the far greater health risks of smoking. Nicotine pouches are presented as a lower-risk, smoke-free alternative that can help adults move away from combustible cigarettes. Concerns about youth marketing are acknowledged, but strong restrictions, flavour bans and high taxes may make these products less accessible to adults who smoke. Canada is used as an example of how strict regulation can encourage illicit markets, where products are not age-gated and may contain higher nicotine levels. A more effective approach would regulate nicotine pouches responsibly while recognising their potential role in reducing smoking-related disease.

June 01, 2026 by businesstech.co.za

Switching from cigarettes to non-combustible nicotine alternatives is linked not only to benefits for smokers, but also to improvements for the people closest to them. Loved ones reported better quality of life, improved emotional wellbeing and more positive shared experiences when smokers moved to products such as vapes, heated tobacco or nicotine pouches. The findings suggest that harm reduction can have wider household and social benefits, including less exposure to smoke, fewer unpleasant smells and improved relationships. Support for adult access to safer nicotine alternatives was high across the countries surveyed, especially among those who had seen someone quit smoking with these products. Policies that treat vaping and smoking in the same way risk ignoring the very different risk profiles of these products and the real-life benefits reported by smokers and their families.

June 01, 2026 by clivebates.com

Global tobacco policy has become increasingly disconnected from the main cause of tobacco-related disease: smoking itself. Safer nicotine products such as vapes, nicotine pouches and heated tobacco products are presented as part of the solution, yet many health authorities continue to treat them as a threat rather than an opportunity for harm reduction. Misleading statistics, particularly around youth vaping, can encourage policies that fail to reduce smoking and may unintentionally push people back towards cigarettes. Strong restrictions and bans risk expanding illicit markets while making safer alternatives harder for adults who smoke to access. A more effective approach would be evidence-based, risk-proportionate regulation that recognises the significant differences between combustible cigarettes and smoke-free nicotine products.

June 01, 2026 by clivebates.com

Global tobacco policy has become increasingly disconnected from the main cause of tobacco-related disease: smoking itself. Safer nicotine products such as vapes, nicotine pouches and heated tobacco products are presented as part of the solution, yet many health authorities continue to treat them as a threat rather than an opportunity for harm reduction. Misleading statistics, particularly around youth vaping, can encourage policies that fail to reduce smoking and may unintentionally push people back towards cigarettes. Strong restrictions and bans risk expanding illicit markets while making safer alternatives harder for adults who smoke to access. A more effective approach would be evidence-based, risk-proportionate regulation that recognises the significant differences between combustible cigarettes and smoke-free nicotine products.

June 01, 2026 by gfn.tv

Restrictions on safer nicotine products are framed as a threat to individual freedom as well as a public health concern. Policies driven by fear rather than evidence can make it harder for adults who smoke to access less harmful alternatives. Bans, high taxes and strict regulations may also strengthen illicit markets, leaving consumers with fewer safe and legal options. The piece challenges the idea that prohibition protects the public, arguing that it often creates new risks while ignoring personal responsibility. A more balanced approach would recognise adult choice, reduce harm and avoid treating all nicotine use as a moral failure.

May 29, 2026 by substack.com

World No Tobacco Day is renewing debate over whether global tobacco control should focus more on engagement with smokers rather than exclusion or stigma. Harm reduction advocates argue that people who smoke are more likely to benefit from accurate information, practical support and access to lower-risk alternatives than from shame-based messaging. The discussion highlights concerns that abstinence-only approaches may overlook the behavioural realities of nicotine dependence and the needs of smokers who have not quit through conventional methods. A more inclusive public health strategy would prioritise empathy, risk reduction and evidence-based pathways away from combustible tobacco.

May 29, 2026 by substack.com

Risk analysis of nicotine and tobacco products requires a clear distinction between combustible smoke exposure and non-combustible forms of nicotine delivery. Evidence on cancer and non-cancer risks continues to show that the greatest health burden is linked to toxicants produced through combustion, rather than nicotine itself. Researchers argue that comparing products through relative risk, exposure levels and disease pathways is essential for avoiding misleading conclusions in public health communication. The analysis reinforces the importance of evidence-based regulation that recognises meaningful differences between cigarettes, vaping products and other smoke-free nicotine alternatives.

May 27, 2026 by regulatorwatch.com

Longstanding public health narratives around nicotine are facing renewed scrutiny as tobacco harm reduction challenges older assumptions shaped by the cigarette era. Critics argue that framing nicotine itself as the central danger has contributed to public misunderstanding of reduced-risk products such as vapes, where the main issue is not combustion but the delivery of nicotine without smoke. The discussion raises concerns that fear-based language, including terms such as “epidemic” and misleading comparisons with illicit drugs, may distort risk perception and weaken evidence-based policy. Broader questions remain over whether tobacco control can adapt to scientific evidence on relative risk while maintaining credible public health communication.

May 27, 2026 by regulatorwatch.com

Longstanding public health narratives around nicotine are facing renewed scrutiny as tobacco harm reduction challenges older assumptions shaped by the cigarette era. Critics argue that framing nicotine itself as the central danger has contributed to public misunderstanding of reduced-risk products such as vapes, where the main issue is not combustion but the delivery of nicotine without smoke. The discussion raises concerns that fear-based language, including terms such as “epidemic” and misleading comparisons with illicit drugs, may distort risk perception and weaken evidence-based policy. Broader questions remain over whether tobacco control can adapt to scientific evidence on relative risk while maintaining credible public health communication.